Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, February 22, 2025.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Long-Term Uptrend (+90) - XERS is in a strong uptrend that is likely to continue. While XERS is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been UP since Jul 16th, 2024 at 2.510
The intermediate-term trend has been UP since Jan 30th, 2025 at 3.670
The short-term trend has been UP since Feb 13th, 2025 at 3.615
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 4.0100 | 4.0103 | 3.6900 | 3.7550 | -0.2150 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.7500 | 2174124 | 2025-02-21 15:59:57 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 4.1 | 52wk High Date | 2025-02-20 |
| 52wk Low | 1.69 | 52wk Low Date | 2024-04-26 |
| Average Volume | 1,812,558 | Shares Outstanding | 149,081 |
| Market Cap | 275M | Assets | 321,104,000M |
| Liabilities | 349,427,000M | P/E Ratio | -4.52630000 |
| Volatility | 56.41 |